Filing Details

Accession Number:
0000950170-25-047889
Form Type:
13G Filing
Publication Date:
2025-03-30 20:00:00
Filed By:
Invus Public Equities, L.P.
Company:
Inventiva S.a. (NASDAQ:IVA)
Filing Date:
2025-03-31
SEC Url:
13G Filing
Ownership Summary

Please notice the below summary table is generated without human intervention and may contain errors. Please refer to the complete filing displayed below for exact figures.

Name Beneficially Owned Number of Shares Beneficially Owned Number of Aggregate Shares Percent of Class
Invus Public Equities, L.P. 0 7,407,406 7.8%
Invus Public Equities Advisors, LLC 0 7,407,406 7.8%
Invus Global Management, LLC 0 7,407,406 7.8%
Siren, L.L.C. 0 7,407,406 7.8%
Raymond Debbane 0 7,407,406 7.8%
Filing





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Checkbox not checked   Rule 13d-1(b)
Checkbox checked   Rule 13d-1(c)
Checkbox not checked   Rule 13d-1(d)






SCHEDULE 13G



Comment for Type of Reporting Person:  Reflects ownership as of the filing date. As of October 17, 2024, Invus Public Equities, L.P. directly held 7,182,792 Ordinary shares, nominal value Euro 0.01 per share (the "Shares") of Inventiva S.A. (the "Issuer"). There is no CUSIP number assigned to the Shares. The CUSIP Number 46124U107 has been assigned to the American Depositary Shares ("ADS") of the Issuer, which are quoted on the Nasdaq Global Market under the symbol "IVA". Each ADS represents 1 Share.


SCHEDULE 13G



Comment for Type of Reporting Person:  Reflects ownership as of the filing date. As of October 17, 2024, Invus Public Equities, L.P. directly held 7,182,792 Ordinary shares, nominal value Euro 0.01 per share (the "Shares") of Inventiva S.A. (the "Issuer"). There is no CUSIP number assigned to the Shares. The CUSIP Number 46124U107 has been assigned to the American Depositary Shares ("ADS") of the Issuer, which are quoted on the Nasdaq Global Market under the symbol "IVA". Each ADS represents 1 Share.


SCHEDULE 13G



Comment for Type of Reporting Person:  Reflects ownership as of the filing date. As of October 17, 2024, Invus Public Equities, L.P. directly held 7,182,792 Ordinary shares, nominal value Euro 0.01 per share (the "Shares") of Inventiva S.A. (the "Issuer"). There is no CUSIP number assigned to the Shares. The CUSIP Number 46124U107 has been assigned to the American Depositary Shares ("ADS") of the Issuer, which are quoted on the Nasdaq Global Market under the symbol "IVA". Each ADS represents 1 Share.


SCHEDULE 13G



Comment for Type of Reporting Person:  Reflects ownership as of the filing date. As of October 17, 2024, Invus Public Equities, L.P. directly held 7,182,792 Ordinary shares, nominal value Euro 0.01 per share (the "Shares") of Inventiva S.A. (the "Issuer"). There is no CUSIP number assigned to the Shares. The CUSIP Number 46124U107 has been assigned to the American Depositary Shares ("ADS") of the Issuer, which are quoted on the Nasdaq Global Market under the symbol "IVA". Each ADS represents 1 Share.


SCHEDULE 13G



Comment for Type of Reporting Person:  Reflects ownership as of the filing date. As of October 17, 2024, Invus Public Equities, L.P. directly held 7,182,792 Ordinary shares, nominal value Euro 0.01 per share (the "Shares") of Inventiva S.A. (the "Issuer"). There is no CUSIP number assigned to the Shares. The CUSIP Number 46124U107 has been assigned to the American Depositary Shares ("ADS") of the Issuer, which are quoted on the Nasdaq Global Market under the symbol "IVA". Each ADS represents 1 Share.


SCHEDULE 13G


 
Invus Public Equities, L.P.
 
Signature:/s/ Raymond Debbane
Name/Title:Raymond Debbane, President, Invus Public Equities Advisors, LLC, its general partner
Date:03/31/2025
 
Invus Public Equities Advisors, LLC
 
Signature:/s/ Raymond Debbane
Name/Title:Raymond Debbane, President
Date:03/31/2025
 
Invus Global Management, LLC
 
Signature:/s/ Raymond Debbane
Name/Title:Raymond Debbane, President
Date:03/31/2025
 
Siren, L.L.C.
 
Signature:/s/ Raymond Debbane
Name/Title:Raymond Debbane, President
Date:03/31/2025
 
Raymond Debbane
 
Signature:/s/ Raymond Debbane
Name/Title:Raymond Debbane
Date:03/31/2025
Exhibit Information

Exhibit Number Title 99.1. Joint Filing Agreement